FTI
82
-2
ALLE
46
-7
EXPE
85
-3
PH
74
-6
AME
65
-6
KSS
52
-4
KO
46
5
CI
52
3
SIG
49
-6
PRGO
36
-3
STT
73
-4
WYNN
34
-3
CFG
93
-2
PCG
66
5
RRC
65
12
CA
21
-6
PNR
66
-2
CMG
54
4
JCI
51
-6
LEG
62
-2
FTI
82
-2
ALLE
46
-7
EXPE
85
-3
PH
74
-6
AME
65
-6
KSS
52
-4
KO
46
5
CI
52
3
SIG
49
-6
PRGO
36
-3
STT
73
-4
WYNN
34
-3
CFG
93
-2
PCG
66
5
RRC
65
12
CA
21
-6
PNR
66
-2
CMG
54
4
JCI
51
-6
LEG
62
-2
Financhill
Back

BNY Mellon Ultra Short Income ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
28

BKUI
BNY Mellon Ultra Short Income ETF

Last Price:
$49.83
Seasonality Move:
0.14%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.68
Seasonality Move:
11.58%
Sell
28
BNY Mellon Ultra Short Income ETF (BKUI) is a Sell

Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?

  • The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.83. The Score for BKUI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BKUI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKUI Stock Price Chart

What is BNY Mellon Ultra Short Income ETF's stock price today?

  • The BNY Mellon Ultra Short Income ETF share price today is $49.83
    The current trend is relatively stagnant and BKUI is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

BKUI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50 Sell
Chaikin Money Flow: 6770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.79 - 49.87) Sell
Bollinger Bands (100): (49.78 - 49.9) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

BKUI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.8 Buy
20-day SMA: 49.83 Sell
50-day SMA: 49.84 Sell
200-day SMA: 49.79 Buy
8-day EMA: 49.81 Buy
20-day EMA: 49.83 Buy
50-day EMA: 49.84 Sell
200-day EMA: 49.79 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

BNY Mellon Ultra Short Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):